Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of DA-302168S Tablets

NCT06534320 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight and Obesity

Interventions

DRUG: DA-302168S
DRUG: Placebo of DA-302168S
DRUG: DA-302168S
DRUG: Placebo of DA-302168S

Sponsor

Chendu DIAO Pharmaceutical Group CO., LTD.